البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)
Aspirin
NorthStar Healthcare Unlimited Company
B01AC06
Aspirin
75mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02090000; GTIN: 05051089990893
Q2344 Q2344 THIS LEAFLET WAS LAST REVISED IN MARCH 2020 اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aspirin 75mg Dispersible Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aspirin 75mg Excipient with known effect Lactose 0.0275g For the full list of Excipients, see section 6.1 3 PHARMACEUTICAL FORM Dispersible tablets. White, flat tablets, embossedon one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the secondary prevention of thrombotic cerebrovascular or cardiovascular disease and following by-pass surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The advice of a doctor should be sought before commencing therapy for the first time. The usual dosage, for long term use, is 75-150mg once daily. In some circumstances a higher dose may be appropriate, especially in the short term, and up to 300 mg a day may be used on the advice of a doctor. Do not give to children aged under 16 years, unless specifically indicated (e.g. for Kawasaki’s disease). Method of administration Oral Tablets should be dissolved in water before being taken. Gastro-intestinal irritation may be reduced by taking aspirin with or immediately after food. 4.3 CONTRAINDICATIONS • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. In patients with a history of hypersensitivity to aspirin (or any of the excipients) or any other NSAIDs and in patients in whom attacks of asthma, angioedema, urticaria or rhinitis have been precipitated by aspirin or other NSAIDs. • Children under 16 years unless specifically indicated (e.g. for Kawasaki’s disease)._ _ • Active peptic ulceration or a history of peptic ulceration • Haemophilia,_ _other coagulopathies or concurrent anticoagulant therapy._ _ • Before commencing long-term aspirin therapy for the management of cardiovascular or cerebrovascular disease patients should consult their doctor who can advise on the relative benefits of aspirin versus the risks for the individual patient. • Gout • Doses > 100mg/day during the third trimester of pregnancy. 4. اقرأ الوثيقة كاملة